Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Blood (2024) 144 (Supplement 1): 4434.

https://doi.org/10.1182/blood-2024-210689

Published: 2024

Journal Articles

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

Nikhil P. Mankuzhy, Brandon S. Imber, Paige Pammer, Beatrice Fregonese, Adriana Cajo, Gustav Cederquist, Alexandra Dreyfuss, Kaitlyn Lapen, Roshal R. Patel, Zachary R. Moore, Carla Hajj, Gilles Salles, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 3040.

https://doi.org/10.1182/blood-2024-208916

Published: 2024

Journal Articles

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Roshal R. Patel, Alexander Tward, Beatrice Fregonese, Harper Hubbeling, Kaitlyn Lapen, Nikhil P. Mankuzhy, Sandeep S. Raj, Miguel-Angel Perales, Roni Shouval, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 7164.

https://doi.org/10.1182/blood-2024-210814

Published: 2024

Journal Articles

Radiation Therapy in a New Era of Multiple Myeloma Management: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response

Alexandra Dreyfuss, Beatrice Fregonese, Saad Z. Usmani, Sham Mailankody, Brandon S. Imber, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2024-202628

Published: 2024

Journal Articles

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2024-206398

Published: 2024

Journal Articles

A Proof-of-Principle of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: A Phase 1a Pilot Cohort

Brandon S. Imber, Anna Brosoff, Emma Roszak, Devin McAvoy, Kinga K. Hosszu, Alexander P. Boardman, Parastoo B Dahi, Gunjan L. Shah, Michael Scordo, Jae H. Park, Miguel-Angel Perales, Gilles Salles, Maria Lia Palomba, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 3128.

https://doi.org/10.1182/blood-2024-210156

Published: 2024

Journal Articles

Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

Manik Uppal, Ashwath Gurumurthi, Paul A. Hamlin, Lorenzo Falchi, Steven Horwitz, Anita Kumar, Ariela Noy, Jennifer Kimberly Lue, Pallawi Torka, Maria E. Arcila, Ahmet Dogan, Brandon S. Imber, Joachim Yahalom, Olivier Elemento, Andrew D. Zelenetz, Gilles Salles, Erel Joffe

Blood (2024) 144 (Supplement 1): 4346.

https://doi.org/10.1182/blood-2024-198931

Published: 2024

Journal Articles

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

Alex Tward, Roshal R. Patel, Irem Isgor, Pallavi Galera, Katherine Lopez, Beatrice Fregonese, Zachary Moore, Suzanne Wolden, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 3097.

https://doi.org/10.1182/blood-2024-210577

Published: 2024

Journal Articles

CAR T-Cell Therapy for DLBCL with CNS Involvement: Overall Safe and Effective with Limited Efficacy in Patients with Leptomeningeal Disease

Blood (2024) 144 (Supplement 1): 4509.

https://doi.org/10.1182/blood-2024-212274

Published: 2024

Journal Articles

Genomic Correlates of Radiosensitivity in Diffuse Large B Cell Lymphoma

Jennifer Ma, Reith R Sarkar, Manik Uppal, Neil Wijetunga, Gilles Salles, Erel Joffe, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6104.

https://doi.org/10.1182/blood-2023-190846

Published: 2023

Journal Articles

Upfront Radiation Therapy (RT) for Post-Stem Cell Transplant Multiple Myeloma (MM) Patients with Oligo-Relapse/Progressive Disease: Factors Associated with Favorable Outcomes

Beatrice Fregonese, Brandon S. Imber, Alexandra Dreyfuss, Carla Hajj, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 4719.

https://doi.org/10.1182/blood-2023-190770

Published: 2023

Journal Articles

Treatment Outcomes of Limited Stage Grade 3A Follicular Lymphoma

Reith R Sarkar, Jasme Lee, Zhigang Zhang, Andrew D. Zelenetz, Gilles Salles, Joachim Yahalom, Brandon S. Imber

Blood (2023) 142 (Supplement 1): 1681.

https://doi.org/10.1182/blood-2023-191002

Published: 2023

Journal Articles

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Gustav Cederquist, Kathryn Tringale, Carla Hajj, Harper Hubbeling, Jennifer Ma, Alexandra Dreyfuss, Beatrice Fregonese, Gilles Salles, Christian Grommes, Michael Scordo, Lorenzo Falchi, Joachim Yahalom, Brandon S. Imber

Blood (2023) 142 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2023-190236

Published: 2023

Journal Articles

Recent Patterns of Radiotherapy Use in Multiple Myeloma: Clinical Outcomes and Possible Radiologic, Biochemical, and Genomic Correlates of Response

Alexandra Dreyfuss, Beatrice Fregonese, Jennifer Ma, Reith R Sarkar, Gustav Cederquist, Saad Z Usmani, Carla Hajj, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6648.

https://doi.org/10.1182/blood-2023-188172

Published: 2023

Journal Articles

Impact of Response to Systemic Bridging Therapy on Clinical Outcomes and Cytokine Profiles in Patients Receiving CD19- CAR T-Cell Therapy for B-Cell Lymphoma

Beatriz Wills, Roni Shouval, Jessica R. Flynn, Sean M. Devlin, Allison Parascondola, Amethyst Saldia, Brandon S. Imber, Ana Alarcon Tomas, Ivan Landego, Richard J. Lin, Michael Scordo, Parastoo Bahrami Dahi, Gunjan L. Shah, Andrew Ip, Lori A Leslie, Hyung Chan Suh, Gilles Salles, Miguel-Angel Perales, Maria Lia Palomba

Blood (2023) 142 (Supplement 1): 3014.

https://doi.org/10.1182/blood-2023-181116

Published: 2023

Journal Articles

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 4491.

https://doi.org/10.1182/blood-2023-190326

Published: 2023

Journal Articles

Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome

Blood (2023) 142 (Supplement 1): 2123.

https://doi.org/10.1182/blood-2023-187763

Published: 2023

Journal Articles

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

Beatrice Fregonese, Carla Hajj, Silvano Gonzalez, Jisun Lee, Lily Boe, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6281.

https://doi.org/10.1182/blood-2023-190688

Published: 2023

Journal Articles

18F-FDG PET/CT Imaging Biomarkers for CAR-T Cell Therapy Outcomes in Large-B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1639.

https://doi.org/10.1182/blood-2023-179641

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

NARROW

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Radiation Therapy in a New Era of Multiple Myeloma Management: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

A Proof-of-Principle of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: A Phase 1a Pilot Cohort

Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

CAR T-Cell Therapy for DLBCL with CNS Involvement: Overall Safe and Effective with Limited Efficacy in Patients with Leptomeningeal Disease

Genomic Correlates of Radiosensitivity in Diffuse Large B Cell Lymphoma

Upfront Radiation Therapy (RT) for Post-Stem Cell Transplant Multiple Myeloma (MM) Patients with Oligo-Relapse/Progressive Disease: Factors Associated with Favorable Outcomes

Treatment Outcomes of Limited Stage Grade 3A Follicular Lymphoma

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Recent Patterns of Radiotherapy Use in Multiple Myeloma: Clinical Outcomes and Possible Radiologic, Biochemical, and Genomic Correlates of Response

Impact of Response to Systemic Bridging Therapy on Clinical Outcomes and Cytokine Profiles in Patients Receiving CD19- CAR T-Cell Therapy for B-Cell Lymphoma

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

18F-FDG PET/CT Imaging Biomarkers for CAR-T Cell Therapy Outcomes in Large-B-Cell Lymphoma

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only